In Silico Models for Anti-COVID-19 Drug Discovery: A Systematic Review

The coronavirus disease 2019 (COVID-19) is a severe worldwide pandemic. Due to the emergence of various SARS-CoV-2 variants and the presence of only one Food and Drug Administration (FDA) approved anti-COVID-19 drug (remdesivir), the disease remains a mindboggling global public health problem. Devel...

Descripción completa

Detalles Bibliográficos
Autor principal: Onyango, Okello Harrison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287514/
https://www.ncbi.nlm.nih.gov/pubmed/37362912
http://dx.doi.org/10.1155/2023/4562974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287514/
https://www.ncbi.nlm.nih.gov/pubmed/37362912
http://dx.doi.org/10.1155/2023/4562974

Ejemplares similares